NAMI vs NRDS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
NAMI
NRDS
Investment Advisor Scores
NRDS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NAMI | NRDS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 7.5075 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -31.9% | 11.4% | NRDS |
| Earnings Growth | 0.0% | -32.4% | NAMI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 50.2/100 | 47.1/100 | NAMI |
| Profit Margin | -23.9% | 6.1% | NRDS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NAMI
MarkdownPrice below a falling SMA50 (slope -18.1%), weak momentum, RSI 39
NRDS
NeutralMixed signals - no dominant trend phase, RSI 30
Fundamentals Snapshot
| Metric | NAMI | NRDS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 0.0 | 3.3 |
| Trailing P/E | 0.9 | 10.0 |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.3% | 0.1% |
| Gross Margin | 0.1% | 0.9% |
| Operating Margin | -0.1% | 0.1% |
| EPS | 1.93 | 0.78 |
| Dividend Yield | — | — |